Events

Manhattan Institute Capitol Hill Briefing: Off-Label Prescribing and the FDA

 MH

 

WHEN:

WEDNESDAY, OCTOBER 8, 201
10:00 AM – 11:30 AM
REGISTRATION & REFRESHMENTS AT 10:00 AM
PROGRAM BEGINS AT 10:30 AM

WHERE:
CAPITOL HILL
HOUSE SIDE (ROOM TBA)
WASHINGTON, DC

To RSVP, please call 646-839-3375

Please join us as our panel of policy experts, physicians, and legal experts discusses the implications of recent court rulings for the FDA’s ability to regulate truthful off-label speech by companies. Our panelists will explore how an alternative framework could improve communication of valuable scientific information to physicians, who can then deliver better care to their patients.

10:00 – 10:30AM
Registration

10:30 – 11:15AM
Panel Discussion

James R. Copland, Senior Fellow & Director, Center for Legal Polcy, Manhattan Institute

Paul Howard, Senior Fellow & Director, Center for Medical Progress, Manhattan Institute

Coleen Klasmeier, Partner and Global Coordinator, Food, Drug and Medical Device, Regulatory Practice Area Team, Sidley Austin LLP

Gregory Schimizzi MD, Cofounder, Carolina Arthritis Associates (Invited)

11:15 – 11:30AM
Q&A